​

Evommune Ownership | Who Owns Evommune?


OverviewForecastFinancialsChart

Evommune Ownership Summary


Evommune is owned by 92.72% institutional investors, 2.77% insiders, and 4.51% retail investors. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 14.63% of EVMN shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.33% of its assets in Evommune shares.

EVMN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEvommune92.72%2.77%4.51%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eqt fund management s.a r.l.5.29M14.63%$43.68M
Ra capital management3.49M11.09%$80.34M
Pivotal bioventure partners investment advisor1.93M5.33%$15.92M
Rtw investments, lp1.50M4.77%$34.54M
Nan fung group1.44M3.99%$11.90M
Price t rowe associates inc /md/1.12M3.55%$25.73M
Blackrock funding, inc. /de1.15M3.19%$9.53M
Janus henderson group896.70K2.84%$20.62M
Vanguard capital management1.00M2.78%$8.30M
Baker bros. advisors lp847.39K2.69%$19.48M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nan fung group1.44M7.95%$11.90M
Velan capital investment management lp446.25K6.43%$10.26M
Pivotal bioventure partners investment advisor1.93M6.32%$15.92M
Eqt fund management s.a r.l.5.29M4.61%$43.68M
Great point partners325.00K1.72%$7.47M
Ra capital management3.49M0.85%$80.34M
Silverarc capital management594.03K0.57%$4.91M
Andera partners97.36K0.46%$804.21K
Nextbio capital management lp119.06K0.42%$983.46K
Rtw investments, lp1.50M0.34%$34.54M

Top Buyers

HolderShares% AssetsChange
Janus henderson group896.70K0.01%896.70K
Baker bros. advisors lp847.39K0.11%847.39K
Alyeska investment group726.36K0.05%726.36K
Qube research684.71K0.00%654.60K
Silverarc capital management594.03K0.57%594.03K

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase40.06K--1.51M
Bioimpact capital---1.46M
Andera partners97.36K0.46%-1.29M
Eventide asset management---1.21M
Kynam capital management, lp---625.50K

New Positions

HolderShares% AssetsChangeValue
Janus henderson group896.70K0.01%896.70K$20.62M
Baker bros. advisors lp847.39K0.11%847.39K$19.48M
Alyeska investment group726.36K0.05%726.36K$16.70M
Silverarc capital management594.03K0.57%594.03K$4.91M
Freestone grove partners lp337.29K0.05%337.29K$7.75M

Sold Out

HolderChange
Royal bank of canada-585.00
Plante moran financial advisors-1.15K
Strs ohio-1.80K
Mitsubishi ufj kokusai asset management-1.80K
National bank of canada /fi/-2.40K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026107-7.76%33,505,075-3.50%921.00%68-16.05%2484.62%
Jun 30, 202611638.10%34,862,5160.83%960.91%8128.57%1318.18%
Mar 31, 20268137.29%34,361,90526.33%1091.46%613.39%11-
Dec 31, 202559-27,200,904-86-59---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I1.21M3.33%-
Vanguard Morn Total Stk Mkt Idx Investor739.07K2.05%452.27K
Vanguard Total Stock Mkt Idx Inv739.07K2.05%452.27K
Vanguard MStar Total Stk Mkt Idx Invest739.07K2.04%-
US Small-Cap Growth II Equity Comp614.72K1.71%251.99K
RTW Biotech Opportunities Ord600.24K1.65%600.24K
American Century U.S. Small Cap Growth567.83K1.58%190.57K
American Century Small Cap Growth Inv567.83K1.56%-
iShares Russell 2000 ETF379.52K1.05%-
T. Rowe Price New Horizons373.10K1.03%-186.75K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 08, 2026Carver Kyle Chief Financial OfficerBuy$13.26K
Jul 07, 2026KIRSCH ARTHUR S-Buy$133.00K
Jun 22, 2026Drew Janice Suzann Chief of Dev. OperationsSell$452.60K
Jun 22, 2026Patel Jeegar Pravinkumar Chief Scientific OfficerSell$33.48K
Jun 22, 2026Pena Luis C. President & CEOSell$168.92K

EVMN Ownership FAQ


Who Owns Evommune?

Evommune shareholders are primarily institutional investors at 92.72%, followed by 2.77% insiders and 4.51% retail investors. The average institutional ownership in Evommune's industry, Biotech Stocks , is 180.58%, which Evommune falls below.

Who owns the most shares of Evommune?

Evommune’s largest shareholders are Eqt fund management s.a r.l. (5.29M shares, 14.63%), Ra capital management (3.49M shares, 11.09%), and Pivotal bioventure partners investment advisor (1.93M shares, 5.33%). Together, they hold 31.05% of Evommune’s total shares outstanding.

Does Blackrock own Evommune?

BlackRock is not among the top 10 institutional shareholders of Evommune.

Who is Evommune’s biggest shareholder by percentage of total assets invested?

Nan fung group is Evommune’s biggest shareholder by percentage of total assets invested, with 7.95% of its assets in 1.44M Evommune shares, valued at 11.9M$.

Who is the top mutual fund holder of Evommune shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Evommune shares, with 3.33% of its total shares outstanding invested in 1.21M Evommune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools